सभी उपयोगकर्ता पोस्ट Vaibhav Warade . पुणे , भारत

Catheter Securement Device Market | Global Market Synopsis & Forecast – 2027


Catheter Securement Device Market

Growing demand for catheter securement devices in minimally invasive surgeries and technological advancement is expected to register a CAGR of ~8.2% during the forecast period of 2021 to 2027

The global catheter securement device market is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period.

Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global catheter securement device market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (US) introduced the Hold-n-Place catheter securement device, which is soft, comfortable, and has a flexible design with no hard plastic parts. It provides complete antimicrobial protection.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/9121

Major Key Players:

Some of the key players in the global catheter securement device market are 3M Company (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), C.R. Bard, Inc. (US), Centurion Medical Products (US), ConvaTec Group plc (UK), Merit Medical Systems, Inc. (US), Smiths Medical (US), TIDI Products, LLC (US), M.C. Johnson Company, Inc. (US), DeRoyal Industries, Inc. (US), Cardinal Health (US), BioDerm Inc. (US), Starboard Medical, Inc. (US), and Pepper Medical (US).

FREE SAMPLE

Segment Analysis

The global catheter securement device market has been segmented into product type, application, end user, and region.

By product type, the market has been segregated into arterial, central venous, peripheral, chest drainage tubes, abdominal drainage tubes, epidural, and all-site securement devices.

Central venous is further segmented intoperipherally inserted central catheter (PICC), subclavian, midlines, femoral, portal, and jugular.Peripheralis further segmented into foley, nasogastric tubes,endotracheal tubes,ventriculoperitoneal, and continuous nerve blocks. The abdominal drainage tubessegment is further segmented intopercutaneous endoscopic gastrostomy, jejunal, and umbilical. The peripheral securement devices segment held the majority share in 2020 due to the extensive use of peripheral securement devices for blood transfusions and the administration of intravenous fluids&other medications after surgery.

Based on application, the catheter securement device market is segmentedintocardiovascular,radiology, general surgery, urological, respiratory, and gastric&oropharyngeal.The cardiovascular segment held the largest share in 2020 due to the rising prevalence of cardiovascular disorders such asatrial septal defect, heart valve disease, and coronary artery diseaseacross the globe.

Based on end user, the catheter securement device market is segmented into hospitals & clinics, home healthcare, and diagnostic centers.The hospitals & clinics segment held the largest market share in 2020 due toalarge number of hospitals present across the globe anda vastnumber of surgical procedures performed across these facilities.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/catheter-securement-device-market-9121

Regional Analysis

The market has been divided, by region, into North America, Europe, Asia-Pacific, and the Rest of the World.

North America is likely to dominate thecatheter securement device market in 2020,owing to thehigh prevalence of chronic diseasesand the presence of major industry players across the region. In addition, a large number of foreign patients prefer surgical procedures to be conducted in the US due to the easyavailability of high-end advanced resources and well-established healthcare infrastructure. Furthermore, according to the Centers for Disease Control and Prevention (CDC), heart disease was the leading cause of death in the US from 2015 to 2020.Thus, the rising number of patients suffering from heart diseases in the USmay increase the demand forheart-related surgeries and procedures, which, in turn, is likely to increase the demandfor catheter securement devices.

Europe holds the second-largest position in the catheter securement device market due to the increased adoption of minimally invasive surgeries across the region. In addition, countries such as Germany, France, Italy, Spain, and the UK have a large number of aging population, supporting the growth of the catheter securement device market.

Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period due to increasing investment in healthcare infrastructure, improving healthcare facilities. High mortality rates due to chronic diseases such as heart diseases, respiratory diseases, urinary diseases, and diabetesare creating demand for catheter securement devices and driving the region's market growth.

The growth ofthe catheter securement device market in the Rest of the World is attributed to increasing public health awareness and government initiatives to bring more advanced technologies of catheter securement devicesinto the region.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/new-born-screening-market-6561

https://www.marketresearchfuture.com/reports/cholesterol-test-market-8738

https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Global Artificial insemination Market 2022 Size, Share, Growth, Opportunities and forecast to 2027


Artificial insemination Market

Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country.

Global Artificial Insemination Market is expected to register a CAGR of 8.56% during the forecast period and is expected to hit USD 3,409.75 Million by 2027.

The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in women up to the age of 45 are reimbursed, whereas The National Institute for Health and Care Excellence (UK) recommends support until 3 cycles. Belgium, Denmark, the Netherlands, and Slovenia are reputed for their most generous reimbursement policies in Europe, with almost full coverage for up to six cycles. IVF treatments are fully covered by Belgium, Denmark, and Slovenia states. From 2018, in vitro fertilization (IVF) and embryo transfer services and pharmaceuticals are fully financed by Estonian Health Insurance Fund (EHIF). A Policy Audit on Fertility by ESHRE and supported by Merck & Co. was published in 2017. It mentioned a wide range of treatment options are available in the Czech Republic, from Intrauterine Insemination (IUI) to surrogacy. The donor eggs and sperm and embryos are explicitly protected under Czech law, which recommends 100% coverage by mandatory health insurance for up to four IVF cycles and six IUI, for women aged 22-39 years of age. In France, IUI and IVF/ICSI are fully reimbursed for women under 43 years of age, including up to six IUIs (one IUI per menstruation cycle).

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1218

Major Key Players:

MRFR recognizes the following companies as the Key Players in the global artificial insemination market— Vitrolife AB, Genea Limited, Rinovum Women's Health, LLC, Pride Angel, Hi-tech Solutions, Kitazato Corporation, Fujifilm Irvine Scientific, and Rocket Medical.

Segment Analysis

Global Artificial Insemination Market has been segmented based on Type and End User.

The market, based on type, has been segregated into intrauterine, intracervical, and Intratubal.

On the basis of end-user, the artificial insemination market is classified into hospitals & clinics, fertility centers, and home-based.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218

Regional Analysis

Global Artificial Insemination Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas accounted for a larger share of the global artificial insemination market. The large share is majorly attributed to the presence of major manufacturers, increasing adoption of assisted reproductive technologies, technological advancements, and high disposable income. Boost in the reimbursement scenario in the European region, rising government initiatives to promote family planning, an increasing number of patients facing difficulty conceiving, an increasing number of manufacturers, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region. The Asia Pacific region is anticipated to grow at a lucrative CAGR over the forecast period. For instance, according to a study by Inito (India), a Bengaluru-based medical technology company, 27.5 million couples suffered from infertility and were actively seeking children. Also, at least 10-15% of married couples experienced fertility issues in 2019. Currently, most private and public health insurers do not include fertility procedures and treatments under their coverage plans. A research paper in Reproductive Biology and Endocrinology in 2015 assessed the use of various fertility treatments by surveying fertility specialists in France, Germany, Italy, Spain, the UK, the US, China, and Japan. The analysis reported that ART outcomes are varied by country, with the highest percentage of women facing fertility-related issues in the US and China. The availability of a large patient pool is expected to help propel the growth rate of the region.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/microfluidic-devices-market-954

https://www.marketresearchfuture.com/reports/sleeping-bruxism-treatment-market-5422

https://www.marketresearchfuture.com/reports/new-born-screening-market-6561

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Remdesivir Market - Global Industry Growth and Forecast – 2027


Remdesivir Market

Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly.

The growth of the global Remdesivir (COVID 19) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19), are expected to restrain the growth of the global Remdesivir (COVID 19) market.

According to MRFR analysis, Global Remdesivir Market is expected to register a CAGR of 31.2% during the forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027.

Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hunan Warrant Pharmaceutical, Dr. Reddy's Laboratories, and others are some of the major market leaders in Remdesivir. Organic strategies such as product launches, mergers, and collaborations are used by the companies operating on the market to boost their share. Gilead Sciences, Inc., for instance, has announced it will donate 1.5 million doses of the medication for compassionate use. The company has also started manufacturing liquid and freeze-dried ways to improve supplies. UK-based AstraZeneca has approached rival drug maker Gilead Sciences about a potential merger.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/10141

Major Key Players:

Some of the key players in the global remdesivir (COVID 19) market are Gilead Sciences, Inc. (US), Mylan (US), Cipla (India), Hetero Labs (India), and Jubilant Life Sciences (India)

Segment Analysis

Global Remdesivir (COVID 19) market has been segmented based on the Dosage and Distribution Channel.

Based on the dosage, the global remdesivir (COVID 19) market has been segmented into 5mg, 10mg, 50mg, and 100mg. The 100 mg segment is expected to hold the largest market share owing to rise in COVID 19 and 100 mg is specifically used for older people and COVID 19 is affecting more in older people

On the basis of distribution channel, the market has been segmented into hospitals and drug stores. The hospitals are expected to hold a major market share owing to government regulation i.e. the drug can be given in the hospitals only.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/remdesivir-market-10141

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2020, owing to the growing cases of COVID 19 in the region. The remdesivir (COVID 19) market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European remdesivir (COVID 19) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The remdesivir (COVID 19) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing rate of COVID 19 cases, the market in Asia-Pacific is expected to be the fastest-growing. The remdesivir (COVID 19) market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/cardiac-rehabilitation-devices-market-2069

https://www.marketresearchfuture.com/reports/artificial-heart-market-7985

https://www.marketresearchfuture.com/reports/surgical-blades-market-8107

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

COVID Testing Kit Market 2022 Global Opportunities and forecast to 2027


COVID Testing Kit Market

According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth.

Global COVID Testing Kit Market is expected to have a market value of USD 97,903.2 Million by 2027.

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Ltd. (China), Dynamiker Biotechnology (Tianjin) Co., Ltd (China), Biomedomics Inc. (US), Safecare Biotech (Hangzhou) Co., Ltd (China), Ortho Clinical Diagnostics (US), Innovita Biological Technology Co., Ltd (China), Guangdong Hecin Scientific, Inc. (China), Advaite, Inc. (US), Mylab Discovery Solutions Pvt. Ltd (India), BGI Group (China), and others.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/9715

Segment Analysis

Global COVID Testing Kit is segmented based on type and application. The global COVID testing kit market, by type, has been segmented into rapid test kit, RT-PCR, and others. The global COVID testing kit market, by application, has been segmented into hospitals, clinics, and others. The hospital segment accounted for the largest market share owing to the high adoption of advanced diagnostic technologies among healthcare professionals.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/covid-testing-kit-market-9715

Regional Analysis

Global COVID Testing Kit Market, based on region, has been divided into Europe, the Americas, Asia-Pacific, and Middle East & Africa.

The European market for the COVID testing kit market, by country, been divided into Russia, Germany, Spain, Italy, the UK, France, and the Rest of Europe. Europe accounted for the largest market share in the global COVID testing kit market

The Americas COVID testing kit market has been divided, by country, into North America and Latin America. The North American COVID testing kit market has been further divided into the US and Canada, whereas the Latin American COVID testing kit market is sub-segmented into Brazil, Argentina, Mexico, Colombia, and the rest of Latin America. Regulatory bodies such as the Food and Drugs Administration (FDA) have given emergency use authorizations (EUA) for various diagnostics kits and devices to manage the shortage of diagnostic devices. For instance, in March 2020, the US FDA issued a EUA for a molecular point of care test kit by Abbott for the rapid detection of COVID-19.

The Asia-Pacific market for the COVID testing kit market has been further divided into India, Australia, South Korea, Japan, China, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Taiwan, and Rest of Asia-Pacific.

The Middle East & Africa COVID testing kit market has been bifurcated into the Middle East and Africa. The Middle Eastern market for the COVID testing kit has been further divided into Turkey, the United Arab Emirates, Saudi Arabia, and the Rest of the Middle East. Rising cases in the UAE, Saudi Arabia, and other countries are set to push the demand for diagnostic kits. For instance, as on 8th June 2020, the total cases in Saudi Arabia were 105,283.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/asia-pacific-integrated-operating-room-systems-market-6232

https://www.marketresearchfuture.com/reports/lice-treatment-market-7134

https://www.marketresearchfuture.com/reports/oral-anticoagulants-market-7718

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Global AI in Drug Discovery Market - Drivers, Opportunities and Forecast Analysis to 2027


AI in Drug Discovery Market

The growth of the global AI in drug discovery market is driven by various factors such as investments by industry giants into the AI business, increasing number of startups operating in AI spectrum for healthcare including drug discovery, machine learning, and other AI technologies and increased use of AI technology by major pharma companies in the drug discovery.

According to MRFR analysis, the Global AI in Drug Discovery Market is expected to register a CAGR of 40.8% during the forecast period and is anticipated to reach USD 2,015.1 Million by 2025.

In addition, the increasing number of cross-industry partnerships for achieving the common goal of improvement in the drug development outcomes is another factor for the growth of the AI in the drug discovery market. Below is the chart representing the number of AI-driven deals each of the Big Biopharma companies have disclosed till March 2019.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/9393

Major Key Players:

Players leading the global AI in drug discovery market include Microsoft Corporation, IBM Corporation, Alphabet Inc., Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI, Exscientia, Cyclica, Bioage, Numerate, Numedii, Inc., Envisagenics, Twoxar, Incorporated, Owkin, Inc., Xtalpi, Inc., Verge Genomics, and Berg LLC, among others.

Segment Analysis

The report is segmented into seven dynamics;

By Product Type : Services and Software.

By Molecule Type: Large and Small Molecules.

By Technology : Machine Learning, Deep Learning, and others.

By Indication : Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, and others.

By Application : Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization & Repurposing, Preclinical Testing, and others.

By End-User : Pharmaceutical & Biotechnology Companies, Research Centers and Academic & Government Institutes, Contract Research Organizations, and others.

By Regions : Americas, Europe, Asia Pacific, and Rest-of-the-World.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region is expected to be the largest market owing to the number of big AI platform developers present in the region, such as Microsoft Azure, TensorFlow, and Google AI. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. Increasing demand for AI solutions by the pharmaceutical players such as AbbVie, Genentech, Amgen, and Eli Lilly and Company, among others, is pushing the market growth in the region. The European AI in drug discovery market is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. High demand for AI platforms and increasing integration into the drug discovery by major players such as Novartis, AstraZeneca, GSK, BI, BMS, and Sanofi, among others, are expected to drive the growth of AI in drug discovery market in the European region.

The AI in drug discovery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to increasing R&D activities in the region and increasing adoption of the AI technologies by the pharma companies in countries like China and India, the market in Asia-Pacific is expected to grow at a significant rate during the forecast. The AI in drug discovery market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/digital-clinical-workspaces-market-5713

https://www.marketresearchfuture.com/reports/amblyopia-market-4353

https://www.marketresearchfuture.com/reports/angiography-equipment-market-6106

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Thalassemia Treatment Market, Opportunities, Size, Share, Trends Analysis and Forecast to 2027


Thalassemia Treatment Market

Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia.

According to MRFR analysis, Thalassemia Treatment Market is expected to register a CAGR of 10.4% during the forecast period and was valued at USD 1890.4 Million in 2018.

The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to curb the growth of the global thalassemia treatment market.

The global thalassemia treatment market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/8595

Major Key Players:

Some of the Key Players in the Global Thalassemia Treatment Market are Novartis AG (Switzerland), Kiadis Pharma (Netherlands), Sangamo Therapeutics (US), Gamida Cell (Israel), Acceleron Pharma, Inc. (US), CELGENE CORPORATION (US), and Bluebird Bio, Inc. (US).

Segment Analysis

The Global Thalassemia Treatment Market has been segmented based on type, treatment, and end-user.

The market, based on type, has been divided into alpha-thalassemia and beta-thalassemia. The alpha-thalassemia segment is likely to be the fastest during the forecast period as there is an increased incidence of alpha-globin disorders in the US and other Western nations.

The global thalassemia treatment market has been segmented based on treatment, into blood transfusions, iron chelation therapy, folic acid supplements, gene therapy, and bone marrow transplants. The blood transfusions segment is expected to be the fastest market as low risks are involved due to careful blood screening. For instance, about 56,000 population have major thalassemia, and there are at least 30,000 people that need regular blood transfusions to survive and 5,500 die perinatally due to alpha-thalassemia major. As a result, increasing the need for blood transfusions would boost the growth of the thalassemia treatment market.

The end-user segment of the market includes hospitals and clinics, diagnostic laboratories, and others. The hospitals and clinics segment is expected to hold the largest share of the market due to the increase in the number of hospital admissions for the treatment of thalassemia across the globe.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/thalassemia-treatment-market-8595

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of thalassemia and rising per capita healthcare expenditure. The thalassemia treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European thalassemia treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The thalassemia treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing government initiatives to promote the thalassemia treatment technique is expected to boost the growth of the thalassemia treatment market in Asia-Pacific and is expected to be the fastest-growing. The thalassemia treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/pregnancy-test-kits-market-2982

https://www.marketresearchfuture.com/reports/varicocele-treatment-market-3900

https://www.marketresearchfuture.com/reports/anti-ageing-drugs-market-3504

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Healthcare Cyber Security Market Professional Survey and In-depth Analysis Research Report Foresight to 2027


Healthcare Cyber Security Market

Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime.

Healthcare Cyber Security Market is expected to register a CAGR of 11.82% during the forecast period, with a market value of USD 16,393.15 Million till 2025.

The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, factors such as lack of adoption of updated software and limited awareness about cybersecurity healthcare are likely to hamper the market growth during the forecast period.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/7612

Major Key Players:

MRFR recognizes the following companies as the Key Players in the Global Healthcare Cyber Security Market—Cisco Systems, Inc. (US), IBM (US), McAfee, LLC (Canada), Symantec Corporation (US), FireEye, Inc. (US), Palo Alto Networks, Inc. (US), DXC Technology Company (US), Trend Micro Incorporated (Japan), Booz Allen Hamilton Inc. (US), and SENSATO CYBERSECURITY SOLUTIONS (US).

Segment Analysis

The Global Healthcare Cyber Security Market has been segmented into threat type, solution type, and end user. By threat type, the market has been segmented into distributed denial-of-service (DDOS), malware, advanced persistent threat (APT), and others. Based on solution type, the global healthcare cybersecurity market has been segregated into risk and compliance management, antivirus and antimalware, security information and event management (SIEM), DDOS mitigation, identity and access management, and others.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/healthcare-cyber-security-market-7612

Regional Analysis

The Global Healthcare Cyber Security Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are expected to hold the largest share of the global healthcare cybersecurity market. This is owing to the increasing case of data breaching, rising cyberattacks on pharmaceutical companies, and healthcare facilities are boosting the market growth in this region.

The Europe market holds the second-largest position in the global healthcare cybersecurity market due to the high spending on healthcare IT, the presence of a large number of pharmaceutical companies, and innovation of new software to protect the healthcare data boosts the market growth in this region.

Asia-Pacific is estimated to be the fastest-growing region owing to the rapid development in technology, and the presence of enormous opportunities for the development of the market drives the growth of the Asia-Pacific healthcare cybersecurity market.

The healthcare cybersecurity market in the Middle East & Africa accounts for the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/human-genetics-market-714

https://www.marketresearchfuture.com/reports/ureteral-stents-market-1389

https://www.marketresearchfuture.com/reports/renal-dialysis-market-1409

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Uveitis Treatment Market, Opportunities, Size, Share, Trends Analysis and Forecast to 2027


Uveitis Treatment Market

Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis.

The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period.

According to MRFR analysis, Uveitis Treatment Market is expected to register a CAGR of 5.6% during the forecast period and was valued at USD 534.6 million in 2018.

The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to strengthen their market positions.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/8457

Major Key Players:

Some of the key players in the Global Uveitis Treatment Market are Allergan PLC, Novartis AG, Bausch Health, EyePoint Pharmaceuticals, Inc., AbbVie Inc., Horizon Therapeutics PLC, Mylan N.V., and Alimera Sciences.

Segment Analysis

The global uveitis treatment market has been segmented based on type, drug class, and end-user.

The market, based on type, has been divided into anterior uveitis, intermediate uveitis, posterior uveitis, and others. The anterior uveitis is likely to hold maximum market share in the global uveitis treatment market.

The global uveitis treatment market based on drug class has been segregated into corticosteroid drugs, anti-inflammatory drugs, immunosuppressive drugs, and others. The corticosteroids drugs segment is anticipated to hold the largest share in the market due to the rising preference in the treatment of uveitis.

The end-user segments of the market are hospitals, specialty clinics, and others. The hospital's segment is expected to hold the largest share of the market, as these are the primary locations where patients receive treatment.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/uveitis-treatment-market-8457

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share owing to the increasing prevalence of uveitis, the presence of a well-established healthcare sector, and high R&D expenditures. The uveitis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European uveitis treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The uveitis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool and expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest-growing. The uveitis treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/artificial-insemination-market-1218

https://www.marketresearchfuture.com/reports/artificial-cervical-disc-market-10608

https://www.marketresearchfuture.com/reports/catheter-securement-device-market-9121

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Gene Therapy Market Global Market Demand, Opportunities, Key Players and Forecast to 2027


Gene Therapy Market

Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets.

According to MRFR analysis, the global gene therapy market is expected to register a CAGR of 40.7% during the forecast period and was valued at USD 524 million in 2018.

The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/8399

Major Key Players:

Some of the key players in the global gene therapy market are Amgen, Inc. (US), Novartis AG (Switzerland), Spark Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), uniQure N.V. (Netherlands), Orchard Therapeutics plc (UK), Celgene Corporation (US), Bristol-Myers Squibb Company (US), Thermo Fisher Scientific Inc. (US), CEVEC (Germany), and Lonza (Switzerland).

Segment Analysis

The global gene therapy market has been segmented based on product, indication, and end user.

The market, based on product, has been divided into kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo, imlygic, and others.

The global gene therapy market has on the basis of indication is segmented, into oncology, genetic diseases/ disorders, and others. The oncology segment is expected to hold the largest market share and to be the fastest-growing segment due to high prevalence of cancer and robust pipeline for cancer gene therapy.

The end-user segments of the market are hospitals & clinics, specialty treatment centers, and others. The hospitals & clinics segment is expected to hold the largest market share due to increasing number of hospitals. Also, hospitals are generally the first treatment choice for diseases.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/gene-therapy-market-8399

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of gene therapy and rising per capita healthcare expenditure. The gene therapy market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European gene therapy market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The gene therapy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing number of patients and raising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The gene therapy market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/narcolepsy-market-5701

https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

https://www.marketresearchfuture.com/reports/bone-metastasis-market-5776

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
1

Global Skin Tightening Market, Opportunities, Top Key Players and Forecast to 2027


Skin Tightening Market

According to International Society of Aesthetic Plastic Surgery (ISAPS), in 2016, estimated the total procedure for skin tightening performed worldwide are 511,481 out of which Japan held the highest number of procedures followed by the US. The factors that propel the growth of the market are growing geriatric population, increasing advancement in medical technology and the emerging medical aesthetic market.

The Global Skin Tightening Market is forecasted to be valued at USD 6,340.99 Million by 2025 with the CAGR of 6.2% during the forecast period.

However, the radiation emitted from skin tightening equipment involve high health-related risk and the stringent government regulations for aesthetic in healthcare is hampering the growth of the skin tightening market.

In the current scenario, several players are dominating the global skin tightening market. The market leaders in skin tightening treatment are involved in merger and acquisition, product development and innovation to increase the foothold in the skin tightening market. For instance, in January 2017, Lynton Lasers launched a stand-alone platform, LUMINA laser & IPL platform, which can perform 24 different aesthetic concern including skin tightening.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2676

Major Key Players:

Some of the key players in the global skin tightening market are ALLERGAN (US), Solta Medical (US), Venus Concept (Canada), SmarterSkin Dermatology (US), INMODE (US), Fotona d.o.o. (Slovenia), BTL (US), Lynton Lasers (UK), EINS MED Co., Ltd (South Korea), ENDYMED MEDICAL (US), and Alma Lasers (Israel).

Segment Analysis

The global skin tightening market has been segmented based on type, portability, application, end user, and region.

The market, based on type, has been divided into radiofrequency skin tightening, laser skin tightening, ultrasound skin tightening, and others. The radiofrequency skin tightening segment is anticipated to hold the largest share in the market due to the wider preferability and long-lasting results.

The market, based on portability, has been segregated into portable and stand-alone. The stand-alone market is expected to hold the largest share in the market, owing to its increasing application in the medical devices industry.

The market, by application, has been categorized as reduce wrinkles, face lifting, anti-aging, and others. The anti-aging segment is expected to lead the market owing to the increasing focus and concern toward having a youthful appearance.

The market, by end user, has been classified as hospitals & clinics, specialty center, and others. The specialty center segment is anticipated to hold a major share in the market due to the professional skin tightening treatments provided in these establishments.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/skin-tightening-market-8245

Regional Analysis

The global skin tightening market, by region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The skin tightening market in the Americas is estimated to hold the largest market share. In 2016, according to ISAPS, the total number of skin tightening procedure performed are 75,834. The European skin tightening market has been sub-divided into Western Europe and Eastern Europe. Germany is expected to hold the largest market share in the European region followed by Italy.

The skin tightening market in Asia-Pacific region is expected to be the fastest-growing market, due to increasing research and development funding by the developing countries like China and India for the development of the healthcare sector. The skin tightening market in the Middle East & Africa region has less economic developments and extremely low-income, therefore anticipated to have the least market share but is expected to grow with better opportunities in the coming years.

Browse Related Reports:

https://www.marketresearchfuture.com/reports/bone-metastasis-market-5776

https://www.marketresearchfuture.com/reports/acute-coronary-syndrome-market-5782

https://www.marketresearchfuture.com/reports/surgical-lights-market-5803

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: [email protected]

Show more
0
2